Christopher A. Tormey
Yale University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher A. Tormey.
Transfusion | 2010
John D. Roback; Stephen Caldwell; Jeffrey L. Carson; Robertson D. Davenport; Mary Jo Drew; Anne F. Eder; Mark K. Fung; Marilyn Hamilton; John R. Hess; Naomi L.C. Luban; Jeremy G. Perkins; Bruce S. Sachais; Aryeh Shander; Toby A. Silverman; Ed Snyder; Christopher A. Tormey; John Waters; Ben Djulbegovic
BACKGROUND: There is little systematically derived evidence‐based guidance to inform plasma transfusion decisions. To address this issue, the AABB commissioned the development of clinical practice guidelines to help direct appropriate transfusion of plasma.
Transfusion | 2008
Christopher A. Tormey; John Fisk; Gary Stack
BACKGROUND: The prevalence of red blood cell (RBC) alloantibodies among general, hospital‐based patients typically has averaged approximately 1 percent in various studies. The frequency and properties of RBC alloantibodies in military veterans has never been examined.
Transfusion | 2009
Christopher A. Tormey; Gary Stack
BACKGROUND: Non‐ABO blood group (BG) alloantibodies can disappear over time, confounding compatibility testing and predisposing patients to delayed hemolytic transfusion reactions. The goal of this study was to analyze BG antibody disappearance after transfusion‐related alloimmunization in men.
American Journal of Clinical Pathology | 2010
Brian R. Smith; Maria E. Aguero-Rosenfeld; John Anastasi; Beverly W. Baron; Anders H. Berg; Jay L. Bock; Sheldon Campbell; Kendall P. Crookston; Robert L. Fitzgerald; Mark K. Fung; Richard L. Haspel; John G. Howe; Jeffrey S. Jhang; Malek Kamoun; Susan M. Koethe; Matthew D. Krasowski; Marie L. Landry; Marisa B. Marques; Henry M. Rinder; William L. Roberts; William E. Schreiber; Steven L. Spitalnik; Christopher A. Tormey; Paul L. Wolf; Yan Yun Wu
As the 100th anniversary of the Flexner report nears, medical student education is being reviewed at many levels. One area of concern, expressed in recent reports from some national health care organizations, is the adequacy of training in the discipline of laboratory medicine (also termed clinical pathology). The Academy of Clinical Laboratory Physicians and Scientists appointed an ad hoc committee to review this topic and to develop a suggested curriculum, which was subsequently forwarded to the entire membership for review. The proposed medical student laboratory medicine curriculum defines goals and objectives for training, provides guidelines for instructional methods, and gives examples of how outcomes can be assessed. This curriculum is presented as a potentially helpful outline for use by medical school faculty and curriculum committees.
Blood | 2009
Christopher A. Tormey; Gary Stack
Blood group antigen immunogenicity is a crucial factor in red blood cell alloimmunization. Previous calculated estimates of immunogenicity suffered from several key shortcomings. To address these issues we have (1) introduced a correction factor for antibody persistence rates into traditional immunogenicity calculations, (2) calculated immunogenicities only in men to eliminate pregnancy-related antibodies, and (3) excluded antibodies reactive only at room temperature to minimize the contribution of naturally occurring antibodies. With these corrections, we have calculated the immunogenicities of common blood group antigens using data collected on clinically significant alloantibodies (n = 452) in a male patient population. We observed a 3- to 5-fold increase in immunogenicity for some antigens (ie, Jk(a), C(w), Lu(a)) and smaller changes in others compared with traditionally calculated estimates. In addition, we have calculated the transfusion-related immunogenicities of antigens traditionally associated with naturally occurring antibodies (eg, anti-Le(a), -Le(b), -M, and -P(1)).
Journal of Experimental Medicine | 2016
Samuele Calabro; Antonia Gallman; Uthaman Gowthaman; Dong Liu; Pei Chen; Jingchun Liu; Jayendra Kumar Krishnaswamy; Manuela Sales Lima Nascimento; Lan Xu; Seema R. Patel; Adam Williams; Christopher A. Tormey; Eldad A. Hod; Steven L. Spitalnik; James C. Zimring; Jeanne E. Hendrickson; Sean R. Stowell; Stephanie C. Eisenbarth
Calabro et al. show that 33D1+ dendritic cells present in the bridging channel of the spleen are essential for alloantibody response to transfused red blood cells.
American Journal of Clinical Pathology | 2011
Jonathan R. Genzen; Christopher A. Tormey
Among the most important functions of a pathology or laboratory medicine service is the clear, accurate, and rapid communication of critical test results (critical values) to patient care providers. Pathologists and laboratory professionals are often confronted with many obstacles in the reporting of such critical values, including establishing clinically relevant criteria for critical values, resolving difficulties in locating an ordering provider when a critical value is obtained, and ensuring that the provider understands the severity and implications of a critical result when he or she has questions. This article presents a hypothetical (yet fairly common) clinical case scenario regarding critical values and then provides an up-to-date discussion and review of the literature on the reporting of critical results.
Transfusion | 2011
Jeanne E. Hendrickson; Eldad A. Hod; Chantel M. Cadwell; Stephanie C. Eisenbarth; David Spiegel; Christopher A. Tormey; Steven L. Spitalnik; James C. Zimring
BACKGROUND: Fourteen‐day stored red blood cells (RBCs) containing an RBC‐specific transgenic antigen (HOD) induce a recipient proinflammatory cytokine storm and are significantly more immunogenic compared to fresh RBCs. Given that recipient mice clear transfused stored RBCs more rapidly than fresh RBCs, we hypothesized that rapid RBC clearance was associated with adverse transfusion outcomes.
Transfusion | 2009
Christopher A. Tormey; Joseph D. Sweeney; Melanie H. Champion; Patricia T. Pisciotto; Edward L. Snyder; Yanyun Wu
BACKGROUND: The goal of this study was to assess transfusion reactions arising from prestorage‐pooled platelet (PSPP) infusions compared with apheresis single‐donor platelets (SDPs) and poststorage‐pooled, whole blood–derived random‐donor platelets (RDPs).
Transfusion | 2010
Christopher A. Tormey; Marie E. Peddinghaus; Michelle L. Erickson; Karen E. King; Melissa M. Cushing; Jerry Bill; Tay Goodrich; Edward L. Snyder
BACKGROUND: The Spectra Optia (SPO; CaridianBCT) is a new apheresis device based on the COBE Spectra (CSP; CaridianBCT) platform. This study was designed to evaluate the safety and efficiency of the SPO in comparison to the predicate CSP device.